Biocon: Launching a New Cancer Drug in India Harvard Case Solution & Analysis

Kiran Majumdar-Shaw, CEO of Biocon to do product launch dates, prices, channels and communications mix decisions related to the launch BioMAb, a new cancer drug in India. "Hide
by Sunil Gupta, Das Narayandas Source: Harvard Business School 15 pages. Publication Date: August 28, 2007. Prod. #: 508026-PDF-ENG

Biocon: Launching a New Cancer Drug in India Case Solution Other Similar Case Solutions like

Biocon: Launching a New Cancer Drug in India

Share This